FWO - Scientific Award AstraZeneca Foundation - Disruptive approaches exploiting cellular genetic defects in cancer 2022
Research
Funding organisation:
Fonds voor Wetenschappelijk Onderzoek - Vlaanderen
What?
The AstraZeneca Foundation attaches great importance to promoting scientific research. On the initiative of the AstraZeneca Foundation, the FWO and F.R.S.-FNRS will give in 2022 a scientific award in recognition of innovative scientific research leading to novel insights on disruptive approaches exploiting cellular genetic defects in cancer.- Prize amounting to 25,000 EURO.
- Rewards innovative scientific research leading to novel insights on disruptive approaches exploiting cellular genetic defects in cancer.
- The prize is intended to reward an established investigator on the basis of his/her previous work, with a perspective of future development in the same field.
Who?
- You have a PhD.
- The applicant must have obtained his/her first PhD degree maximum 15 years before the date of the sumbission deadline (possible extended in case of eligible career breaks, see regulations).
- The prize can only be given to an individual scientist from postdoctoral level onwards who is affiliated to a Belgian university or university hospital. The applicant can have the Belgian or foreign nationality on the condition that he/she has been doing research activities in Belgium in a biomedical context during at least five years prior to the submission deadline.
Application?
- Submit your candidacy using the appropriate form, filled in correctly and completely (in English), on 04 July 2022 at the latest.
- Your candidacy is submitted to a jury.
- The jury selects the laureate for the prize.
Regulations?
Regulations Scientific Award AstraZeneca Foundation – Disruptive approaches exploiting cellular genetic defects in cancer 2022.More information?
More information can be found on the website of FWO.Deadline
04.07.2022
Contact Hasselt University?
E-mail annelies.stockmans@uhasselt.be
Tel. +3211268070